U.S. pharma giant copyright scrapped two experimental weight loss drugs last yr—a once-daily pill, lotiglipron, resulting from elevated liver enzymes in addition to a 2 times-every day pill, danuglipron, as a consequence of potent Uncomfortable side effects—but CEO Albert Bourla has stated the company is decided to “Perform and acquire” fro